Business · 21/11/2019Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Dermatologic and Ophthalmic Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee to gather input on regulatory issues, and is seeking public comments on the matter
Original source language: Federal Register — Food and Drug AdministrationOpen original release →